Navigation Links
MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
Date:4/16/2013

KENNESAW, Ga., April 16, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTC: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the first quarter ended March 31, 2013, will be released before the opening of the market on Wednesday, May 1, 2013. MiMedx will host a live broadcast of its first quarter conference call on Wednesday, May 1, 2013 at 10:30 AM EDT. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com or www.earnings.com.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimall
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
2. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
3. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
4. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
5. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
6. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
7. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
8. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
9. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
10. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
11. MiMedx Group Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... N.C. and PARIS ... firm AgBiome, and Genective, key developer of biotech ... the discovery of new generations of insect control ... insect control to counter the realities of advancing ... Genective, aligning AgBiome,s unique insect control technology with ...
(Date:7/1/2015)... BURLINGTON, Mass. , July 1, 2015 /PRNewswire/ ... three most frequently cited advantages of Otezla are ... favorable safety profile, as reported by surveyed rheumatologists. ... and launched for the treatment of active psoriatic ... . The current standard of care includes conventional ...
(Date:7/1/2015)... ... ... next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares to ... its new report that the market drivers of this vibrant industry include increased payor ... as part of a molecular diagnostics trend. , The global market is forecast to ...
(Date:7/1/2015)... AURORA, Colo. and BANGALORE, India ... a global genomic profiling company that uses next generation ... appointment of Scott A. Storrer as chief ... and CEO, he will be responsible for all strategy, ... Vijay Chandru , who has served as Strand,s chairman ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
... - In a criminal trial, as any fan of TV ... defense goes second. The accused can appear in deep trouble, at ... often carries the day. , ,Not only does that make for ... works in real life. Those who file the charges speak first, ...
... - Midwest Fiber Networks , which has promised Milwaukee ... 2008, has been granted a reprieve by the Milwaukee ... ,The council has voted to give Midwest Fiber until June ... of the citywide wireless network. The company was to have ...
... that the recent U.S. Patent and Trademark Office ... arm of the University of Wisconsin could be ... cell research. , ,As one of the parties who lodged ... embryonic stem cells held by the Wisconsin Alumni Research ...
Cached Biology Technology:Here's why Wisconsin's stem cell patents are being challenged 2Here's why Wisconsin's stem cell patents are being challenged 3Here's why Wisconsin's stem cell patents are being challenged 4Patent ruling doesn't tarnish Wisconsin's stem cell leadership 2Patent ruling doesn't tarnish Wisconsin's stem cell leadership 3
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... of Minnesota researcher has found a universal rule that regulates ... that may also offer a key to calculating their carbon ... order to construct valid models of global carbon dioxide cycling. ... and animals through the process of respiration; Peter Reich, a ...
... A recent study shows that hundreds of genes contribute ... time these genes, many of which are potential contributors ... study. , The group led by Professor Jussi Taipale ... Finland) has identified genes contributing to cell growth and ...
... against the bird flu virus H5N1, derived from horses, ... virus. , A study published today in the ... that a dose of 100 µg of horse anti-serum ... antibodies developed in horses could potentially be used to ...
Cached Biology News:Of mice, men, trees and the global carbon cycle 2Of mice, men, trees and the global carbon cycle 3Genes involved in cell growth and cell division identified 2
Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine p...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Proline-serine-threonine phosphatase-interacting protein 2...
Anti-gamma Glutamyl Transferase (gammaGT) Host: mouse monoclonal Species Reactivity: human Applications: WB, IP, FC Storage: 4C...
Biology Products: